Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-11-002548
Filing Date
2011-08-09
Accepted
2011-08-09 17:11:41
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 774902
2 CERTIFICATION sbfm_ex311.htm EX-31.1 15234
3 CERTIFICATION sbfm_ex312.htm EX-31.2 15287
4 CERTIFICATION sbfm_ex32.htm EX-32 8013
11 img001.jpg GRAPHIC 17258
12 img002.jpg GRAPHIC 25838
  Complete submission text file 0001354488-11-002548.txt   1343956

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbfm-20110630.xml EX-101.INS 31375
6 XBRL TAXONOMY EXTENSION SCHEMA sbfm-20110630.xsd EX-101.SCH 6490
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbfm-20110630_cal.xml EX-101.CAL 15807
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbfm-20110630_def.xml EX-101.DEF 3903
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbfm-20110630_lab.xml EX-101.LAB 52707
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbfm-20110630_pre.xml EX-101.PRE 44450
Mailing Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2
Business Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2 514-496-5197
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 111021817
SIC: 8742 Services-Management Consulting Services